•
Shanghai Vitalgen BioPharma Co., Ltd, a specialist in cell and gene therapy based in China, has entered into a licensing agreement with Suzhou Novoprotein Scientific Co., Ltd, a provider of protein technology and application solutions. Under the terms of the agreement, Novoprotein will secure manufacturing and marketing licenses for AaCas12bMax…